<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nierengarten, Mary Beth</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Paolillo, Joseph</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Early Data Show Benefits of New Device for Closing Congenital Heart Defects</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">18-19</style></pages><abstract><style  face="normal" font="default" size="100%">A new-generation device used in the treatment of transcatheter closure of congenital heart defects provides easier delivery, better septal apposition, and faster endothelialization than an older version of the device. Early clinical experience showed the device to be efficient and successful in closing both atrial septal defects and patent foramen ovales.</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>